Company intelligence / Profile preview

OncoBioPharm

Princeton, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

OncoBioPharm is a biopharmaceutical company focused on the development of innovative therapies for the treatment of various forms of cancer. The company leverages a diverse range of modalities, including small molecules and monoclonal antibodies, to target well-validated oncogenic pathways such as EGFR and VEGF. While currently in the early stages of development, OncoBioPharm aims to address significant unmet medical needs in solid tumors, including breast and lung cancers. Their approach combines internal research with strategic collaborations to advance a pipeline of targeted oncology candidates.

Therapeutic areas: Oncology
Modalities: Small moleculeMonoclonal antibodyAntibody-drug conjugatePeptides
Industry: Biotech

Beyond the preview

Go deeper on OncoBioPharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OncoBioPharm.

Explore the full profile